Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3‐Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?

ConclusionThe present study suggests that mirabegron seems to have priority as an initial therapy with a distinct efficacy/tolerability balance. Mirabegron also represents a reasonable alternative to antimuscarinics for patients who had insufficient efficacy and poor tolerability.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fluts.12153

Source: LUTS: Lower Urinary Tract Symptoms - August 31, 2016 Category: Urology & Nephrology Authors: Minoru KOBAYASHI, Akinori NUKUI, Takao KAMAI Tags: ORIGINAL ARTICLE Source Type: research

More News: Constipation | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology